Study reveals tirzepatide combined with menopause hormone therapy boosts weight loss in postmenopausal women versus tirzepatide alone, potentially offering a more effective weight management solution.
Concerns rise over opioid settlement funds misuse. A new database crowdsources examples of waste and fraud, urging accountability from state attorneys general. $50B+ at stake.
Research shows brain protein cypin is crucial for neuron communication and may combat neurodegenerative diseases like Alzheimer's and Parkinson's by tagging proteins in synapses, boosting memory and learning.
KFF Health News explores healthcare costs, facility impact, and breast cancer screening. Support KHN's independent journalism on health and wellness.
UniSA's injectable levodopa & carbidopa formula offers a week-long, steady drug release for Parkinson's, reducing dosage frequency and improving patient lives. Potential for other chronic conditions.
Allergic vaginitis, triggered by allergens like pollen and dust mites, causes inflammation and irritation. Experts recommend allergy testing and antihistamines for relief. Family history is a factor.
Researchers discover cryorhodopsins, unique proteins in cold environments. They may enable UV sensing and power new brain technologies like light-based hearing aids. Optogenetics and neuroscience applications are considered.
Explore chlorophyll's potential benefits (cancer prevention, weight loss) and risks (side effects, limited scientific evidence). Focus on natural sources over supplements for optimal health.
Study suggests low-dose hydroxychloroquine may reduce COVID-19 mortality in hospitalized patients with severe disease when given early. Emphasizes precision in antiviral application.
Red-state governors stay silent as Trump's policies bring historic Medicaid cuts, impacting healthcare and state budgets. Political risks and fear of Trump's anger stifle open opposition.
Medicaid work requirements threaten coverage for millions, including caregivers like Gallagher, who face bureaucratic hurdles and potential loss of vital healthcare. Work requirements & coverage losses are a concern.
PTEN loss in amygdala inhibitory neurons disrupts brain circuits, increasing anxiety & fear learning in mice, mimicking ASD traits. This unveils targeted treatment potential.
